About Siri Drugs India Private Limited
Data last updated:
Siri Drugs India Private Limited was a private limited company based in Visakhapatnam, Andhra Pradesh, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 24 February 2012.
The company was registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24232AP2012PTC079367.
The company had an authorised share capital of ₹16 Cr and a paid-up capital of ₹7.34 Cr. It was led by directors including Pamidi Ravindra and Prasanth Nandigala.
Its last annual general meeting (AGM) was held on 26 September 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office was at Plot No. 13B Jawaharlal Nehru Pharma City Thanam Parawada Visakhapatnam, Andhra Pradesh, India – 531019.
As per MCA filings, the company had satisfied charges of ₹36 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company.
The last known website on record is siridrugs.com.
Company details
Contact details
Siri Drugs India Private Limited's registered office is in Visakhapatnam, Andhra Pradesh.
- Registered AddressPlot No. 13B Jawaharlal Nehru Pharma City Thanam Parawada Visakhapatnam, Andhra Pradesh, India – 531019
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Siri Drugs India Private Limited
FY 2015 filings availableFinancial Statement Summary
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Siri Drugs India Private Limited, buy the company report.
Board of directors of Siri Drugs India Private Limited
Siri Drugs India has 5 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Teena Tummuri | Additional Director | 17 Oct 2015 | 11 Years 0 Months | As last reported |
| Pamidi Ravindra | Director | 31 Aug 2015 | 11 Years 2 Months | As last reported |
| Prasanth Nandigala Also directs: Virchow Biotech Private Limited, Virchow Laboratories Limited, Saraca Laboratories Limited and 5 more | Director | 31 Aug 2015 | 11 Years 2 Months | As last reported |
| Mundla Maha Vishnu Also directs: Virchow Biotech Private Limited, Virchow Laboratories Limited, Saraca Laboratories Limited and 5 more | Director | 31 Aug 2015 | 11 Years 2 Months | As last reported |
| Hemanth Nandigala Also directs: Virchow Biotech Private Limited, Virchow Healthcare Private Limited, Virchow Laboratories Limited and 2 more | Additional Director | 17 Oct 2015 | 11 Years 0 Months | As last reported |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Nov 2014 | 10540000 | Syndicate Bank | ₹15 Cr | Satisfied | |
| 09 Nov 2013 | 10469421 | State Bank of Hyderabad | ₹21 Cr | Satisfied |
To see the full charge records of Siri Drugs India Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Siri Drugs India Private Limited has 4 court cases on record: 4 filed by Siri Drugs India. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Company petition | Filed by the company | Disposed |
| High Court | Court case (COMPA) | Filed by the company | Disposed |
| High Court | Company petition | Filed by the company | Disposed |
| High Court, ANDHRAPRADESH | Court case (COMPA) | Filed by the company | Disposed |
To see the full case history of Siri Drugs India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Siri Drugs India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Siri Drugs India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Siri Drugs India Private Limited has 17 board changes on record since 2012: 5 appointments and 12 cessations. The latest: Hemanth Nandigala was appointed as Additional Director on 17 Oct 2015.
12 earlier events are in the company report.
Frequently asked questions
Siri Drugs India has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Siri Drugs India was a private limited company based in Visakhapatnam, Andhra Pradesh, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 24 February 2012 and is registered under CIN U24232AP2012PTC079367. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Siri Drugs India was incorporated on 24 February 2012. It is registered with the Registrar of Companies, Vijayawada.
Siri Drugs India had 5 directors:
- Teena Tummuri - Additional Director
- Pamidi Ravindra - Director
- Prasanth Nandigala - Director
- Mundla Maha Vishnu - Director
- Hemanth Nandigala - Additional Director
The CIN (Corporate Identification Number) of Siri Drugs India is U24232AP2012PTC079367. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Siri Drugs India is at Plot No. 13B Jawaharlal Nehru Pharma City Thanam Parawada Visakhapatnam, Andhra Pradesh, India – 531019.
Siri Drugs India can be reached through the website siridrugs.com. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The latest financial statements of Siri Drugs India on record with the MCA are for the year ended 31 March 2015. Its last annual general meeting was held on 26 September 2015. Year-wise statements from 2015 are in the company report.
Siri Drugs India operated in the pharma industry, in the api manufacturers segment.
Siri Drugs India has 4 court cases on record: 4 filed by the company.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
